AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
189.99
+4.37 (2.35%)
At close: Jul 1, 2025, 4:00 PM
191.69
+1.70 (0.89%)
After-hours: Jul 1, 2025, 7:59 PM EDT
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
$1,043,036
Profits / Employee
$75,545
Market Cap
335.60B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ABBV News
- 1 day ago - AbbVie to buy Capstan Therapeutics for up to $2.1 billion - Reuters
- 1 day ago - AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology - PRNewsWire
- 1 day ago - U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance - PRNewsWire
- 1 day ago - AbbVie to Host Second-Quarter 2025 Earnings Conference Call - PRNewsWire
- 1 day ago - This Changes Everything: One Of The Most Important Shifts For Dividend Investors - Seeking Alpha
- 2 days ago - Best Dividend Aristocrats For July 2025 - Seeking Alpha
- 6 days ago - Elahere Market Opportunities and Strategies to 2034: Abbvie Secures European Approval for Elahere in Platinum-Resistant Ovarian Cancer - GlobeNewsWire
- 6 days ago - My Dividend Stock Portfolio: New May Dividend Record - 100 Holdings With 15 Buys - Seeking Alpha